Research Insights Episodes

My guest this week is Dr. Mary Bailey, a neurologist specializing in MS care at the Mandell Center for Multiple Sclerosis in Hartford, Connecticut, and we're talking about some of the changes that occur as relapsing-remitting MS transitions to secondary progressive MS. Since about 80% of the people living with relapsing-remitting MS will experience that transition to secondary progressive MS, I think it's an important conversation to have. Since yesterday was Veterans Day in the United States,...

My guest this week is Dr. Silvana Costa, a research scientist in the Neuropsychology and Neuroscience Center at the Kessler Foundation. Dr. Costa's work is focused on cognitive impairment in MS, specifically, information processing speed, which is something that people living with MS often have to deal with. We'll talk with Dr. Costa about some of her specific research, along with a promising intervention designed to improve cognitive processing speed for people living with MS. We're also talki...

I'm back from attending the MS International Federation's People With MS Forum in Athens, Greece, and it was a remarkable few days spent with some truly remarkable people. In this episode of RealTalk MS, you'll meet two of those remarkable people. First, we'll talk with Dr. Laura Musambayi, the founder of the MS Association of Kenya. Dr. Musambayi will share her experiences in a country of 50 million people, with just 20 neurologists, and no access to disease-modifying therapy. Then, you'll mee...

For almost 20 years, the CLIMB Study has been following thousands of MS patients, discovering so many aspects of multiple sclerosis and documenting how the disease changes over time. My guest is Dr. Tanuja Chitnis, Director of the CLIMB Study, Director of the Partners Pediatric Multiple Sclerosis Center at MassGeneral Hospital for Children, as well as the Director of the Translational Neuroimmunology Research Center at Brigham and Women's Hospital. We're also talking about an emerging topic tha...

I imagine everyone involved in MS research has their own reasons that make it important to them. My guest this week is Dr. Anisha Doshi, and Dr. Doshi's reasons are personal and powerful. Dr. Doshi will also update us on her current research project, and we'll talk with Dr. Doshi about the path that women face as they pursue a career in Neurology. You'll also hear Atara Biotherapeutics Chief Medical Officer Dr. AJ Joshi discuss Atara's clinical trial aimed at mitigating MS by using lab-engineer...

Sometimes, you can just look at someone and know how they're feeling. Our ability to "read people" is called social cognition. And we're learning that people living with MS can lose their social cognition skills, making every face-to-face interaction more difficult. My guest is Dr. Helen Genova, the Assistant Director of the Kessler Foundation's Center for Neuropsychology and Neuroscience Research, the Director of the Social Cognition and Neuroscience Laboratory at the Kessler Foundation, and an...

Being diagnosed with multiple sclerosis means learning to live with a whole new set of challenges. Rising to meet those challenges and learning how to thrive in spite of those challenges is called resilience. But resilience isn't something that you're necessarily born with. Just like a muscle, resilience is something that you can choose to develop. My guest, Dr. Brandon Beaber, specializes in treating people living with MS and he's the author of Resilience in the Face of Multiple Sclerosis, a bo...

Fatigue isn't only a common symptom of MS; it's also one of the most disruptive symptoms of MS. It's hard to be out living life when you're trying to overcome that feeling of just not having any gas left in the tank. My guest is Dr. Ekaterina Dobryakova, a research scientist at the Kessler Foundation's Center for Traumatic Brain Injury Research, where she conducts research in cognitive dysfunction caused by traumatic brain injury and multiple sclerosis. Dr. Dobryakova's research has shown that t...

My guest is Professor Helen Tremlett, who holds the Canada Research Chair in Neuroepidemiology and Multiple Sclerosis at the University of British Columbia, in Vancouver, Canada. Professor Tremlett has been involved in more than 200 published research studies, and we're going to talk about a few of them -- including the research that she's done on the correlation between MS disability progression and socioeconomic status. We're also talking about a study that indicates starting disease-modifyin...

The Charcot Award recognizes lifetime achievement in outstanding research into the understanding and treatment of MS. My guest is Professor Catherine Lubetzki, this year's recipient of the Charcot Award. Professor Lubetzki is being recognized for her very significant contributions to better understanding the underlying disease processes of MS, and her groundbreaking work in furthering our understanding of demylenation and remylenation. Professor Lubetzki is a professor of Neurology at Sorbonne ...